Management of hepatitis C in human immunodeficiency virus-infected patients

R. Bruno, M. Puoti, P. Sacchi, G. Carosi, G. Filice

Research output: Contribution to journalArticle

Abstract

Hepatitis C virus-related liver disease and its associated complications are steadily emerging health concerns in persons co-infected with human immunodeficiency virus. The increasing number of liver-related deaths in human immunodeficiency virus-hepatitis C virus co-infected individuals supports the compelling argument for more aggressive treatment in these patients. The safety and efficacy of interferon/ribavirin in human immunodeficiency virus/hepatitis C virus co-infected patients is currently under evaluation. Despite well-documented concern over highly active antiretroviral therapy-associated hepatotoxicity human immunodeficiency virus/hepatitis C virus co-infected patients should be offered antiretroviral therapy. Since management of co-infected patients is complex a multidisciplinary approach is needed in order to facilitate care and help patients to achieve a positive outcome.

Original languageEnglish
Pages (from-to)452-459
Number of pages8
JournalDigestive and Liver Disease
Volume34
Issue number6
DOIs
Publication statusPublished - 2002

Keywords

  • Co-infection
  • HCV
  • Hepatitis
  • HIV

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Management of hepatitis C in human immunodeficiency virus-infected patients'. Together they form a unique fingerprint.

  • Cite this